Journal of the American Academy of Dermatology
Volume 62, Issue 3 , Pages 418-426, March 2010

Folliculotropic mycosis fungoides: Clinicopathological features and outcome in a series of 20 cases

  • Cristina Muniesa, MD

      Affiliations

    • Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
  • ,
  • Teresa Estrach, MD

      Affiliations

    • Department of Dermatology at Hospital Clínic, IDIBAPS, Barcelona, Spain
  • ,
  • Ramon M. Pujol, MD

      Affiliations

    • Department of Dermatology, Hospital del Mar, IMAS, Barcelona, Spain
  • ,
  • Fernando Gallardo, MD

      Affiliations

    • Department of Dermatology, Hospital del Mar, IMAS, Barcelona, Spain
  • ,
  • Pilar Garcia-Muret, MD

      Affiliations

    • Department of Dermatology, Hospital de Sant Pau, Barcelona, Spain
  • ,
  • Josefina Climent, MD

      Affiliations

    • Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
  • ,
  • Octavio Servitje, MD

      Affiliations

    • Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain
    • Corresponding Author InformationCorrespondence to: Octavio Servitje, MD, Department of Dermatology, Hospital Universitari de Bellvitge, c/Feixa Llarga s/n, ĹHospitalet de Llobregat, 08907-Barcelona, Spain.

Accepted 12 March 2009. published online 18 January 2010.

Background

Folliculotropic mycosis fungoides (MF) is a rare variant of cutaneous T-cell lymphoma in which the neoplastic T lymphocytes display tropism for the follicular epithelium.

Objectives

To better categorize this rare form of cutaneous T-cell lymphoma we evaluated the clinical, pathological, and immunophenotypic findings, and the response to therapy and course of the disease.

Methods

Folliculotropic MF cases were selected from the registry of the Thematic Network of Cutaneous Lymphoma of Barcelona (Spain) from 1988 to 2007.

Results

Twenty patients (11 male, 9 female) with a mean age of 54 years were included. Mean follow-up time was 43 months. The most common sites of involvement were the head and neck (80%), upper extremities, and thorax. Infiltrated plaques (55%), acneiform lesions (comedo-like and epidermal cysts) (45%), and follicular keratosis-pilaris–like lesions (45%) were the more prominent features. Histopathological findings included selective infiltration of the follicular epithelium by atypical lymphocytes in all cases. Mucinous degeneration of the follicular epithelium occurred in 60% of cases. Psoralen plus ultraviolet A therapy was the treatment of choice in the majority of patients, but these patients did not respond as well as patients with classic MF. Radiotherapy (local or total skin electron beam) was found to be the most effective treatment. A good response to bexarotene was seen in some patients.

Limitation

This was a case series descriptive study.

Conclusions

Folliculotropic MF is a rare but well-defined clinicopathological variant of MF. Although refractory to standard therapies used in classic MF, most of our patients showed only slow disease progression.

Key words: cutaneous T-cell lymphoma, folliculotropic mycosis fungoides, mycosis fungoides

Abbreviations used: CTCL, cutaneous T-cell lymphoma, MF, mycosis fungoides, TSEB, total skin electron beam, UV, ultraviolet

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by Fondo de Investigación Sanitaria (FIS) grant PI050458.

 Conflicts of interest: None declared.

 Reprints not available from the authors.

PII: S0190-9622(09)00356-9

doi:10.1016/j.jaad.2009.03.014

Journal of the American Academy of Dermatology
Volume 62, Issue 3 , Pages 418-426, March 2010